Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025)
Dianthus Therapeutics' (DNTH) quarterly FCF Margin came in at 7717.17% in Q3 2025, down 673688.0% year-on-year from N/an in Q3 2024, and up 37.78% quarter-over-quarter from 12403.11% in Q2 2025.
Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' FCF Margin history runs 4 years deep, the most recent figure standing at 7717.17% for Q3 2025.
- On a quarterly basis, FCF Margin fell 673688.0% year-over-year to 7717.17% in Q3 2025; TTM through Sep 2025 was 3519.33%, a 235134.0% decrease from a year earlier, with the FY2024 full-year figure at 1255.57%, up 5267.0% from the prior year.
- FCF Margin grew to 7717.17% in Q3 2025 per DNTH's latest filing, from 12403.11% in the prior quarter.
- Across five years, FCF Margin topped out at 1399.91% in Q3 2022 and bottomed at 12403.11% in Q2 2025.
- The 4-year median for FCF Margin is 1713.16% (2024), against an average of 2589.63%.
- Across the five-year window, FCF Margin surged 52404 bps in 2024 and sank 1162238 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 755.74% in 2022, then slumped by 244 bps to 2596.06% in 2023, then increased by 20 bps to 2072.02% in 2024, then plunged by 272 bps to 7717.17% in 2025.
- Per Business Quant, the three latest DNTH FCF Margin figures stand at 7717.17% (Q3 2025), 12403.11% (Q2 2025), and 2304.5% (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -7,717.17% |
| Jun 30, 2025 | -12,403.11% |
| Mar 31, 2025 | -2,304.50% |
| Dec 31, 2024 | -2,072.02% |
| Sep 30, 2024 | -980.29% |
| Jun 30, 2024 | -780.73% |
| Mar 31, 2024 | -1,713.16% |
| Dec 31, 2023 | -2,596.06% |
| Sep 30, 2023 | -1,088.42% |
| Jun 30, 2023 | -490.40% |
| Mar 31, 2023 | -2,163.45% |
| Dec 31, 2022 | -755.74% |
| Sep 30, 2022 | 1,399.91% |